1. 1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer. (September 2015) Authors: Tamiya, M.; Tamiya, A.; Kaneda, H.; Nakagawa, K.; Goto, K.; Yoh, K.; Okamoto, H.; Shimokawa, T.; Abe, T.; Tanaka, H.; Daga, H.; Takeda, K.; Atagi, S.; Hirashima, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3034 Mutational profile of targetable oncogenes in younger adult patients with lung adenocarcinoma. (September 2015) Authors: Sugiyama, E.; Matsumoto, S.; Mimaki, S.; Tada, S.; Zenke, Y.; Makinoshima, H.; Genichiro, I.; Kirita, K.; Umemura, S.; Yoh, K.; Niho, S.; Ohmatsu, H.; Tsuboi, M.; Tsuchihara, K.; Goto, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3043 Clinicopathological features of patients with ROS1-rearranged advanced non-small cell lung cancer: LC-SCRUM-Japan. (September 2015) Authors: Sugiyama, E.; Matsumoto, S.; Yoh, K.; Ohe, Y.; Seto, T.; Murakami, H.; Iwama, E.; Sugawara, S.; Yamada, K.; Takeda, K.; Hosomi, Y.; Saeki, S.; Yokoyama, T.; Nishio, M.; Satouchi, M.; Tsuta, K.; Kohno, T.; Ishii, G.; Tsuchihara, K.; Goto, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Phase I trial of BI 1810631, a HER2 tyrosine kinase inhibitor (TKI), as monotherapy in patients (pts) with advanced/metastatic solid tumors with HER2 aberrations. (October 2022) Authors: Opdam, F.; Heymach, J.; Barve, M.; Wu, Y.L.; Gibson, N.; Sadrolhefazi, B.; Serra, J.; Yoh, K.; Yamamoto, N. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. First-in-man phase 1 study of TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors. (December 2016) Authors: Doi, T.; Yoh, K.; Shitara, K.; Takahashi, H.; Ueno, M.; Ohkawa, S.; Morimoto, M.; Kobayashi, S.; Okusaka, T.; Ueno, H.; Morizane, C.; Shiba, S.; Furuse, J.; Nagashima, F.; Naruge, D.; Okano, N. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein for patients with chronic hepatitis B and C: a comparative study. Issue 12 (31st July 2016) Authors: Nishikawa, H.; Enomoto, H.; Iwata, Y.; Kishino, K.; Shimono, Y.; Hasegawa, K.; Nakano, C.; Takata, R.; Nishimura, T.; Yoh, K.; Ishii, A.; Aizawa, N.; Sakai, Y.; Ikeda, N.; Takashima, T.; Iijima, H.; Nishiguchi, S. Journal: Journal of viral hepatitis Issue: Volume 23:Issue 12(2016) Page Start: 977 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. T‐bet over‐expression regulates aryl hydrocarbon receptor‐mediated T helper type 17 differentiation through an interferon (IFN)γ‐independent pathway. (31st January 2017) Authors: Yokosawa, M.; Kondo, Y.; Tahara, M.; Iizuka‐Koga, M.; Segawa, S.; Kaneko, S.; Tsuboi, H.; Yoh, K.; Takahashi, S.; Matsumoto, I.; Sumida, T. Journal: Clinical and experimental immunology Issue: Volume 188:Number 1(2017:Apr.) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗